FDA cleared the VIVO (9002) from Catheter Precision, Inc. on Oct 30, 2026 under K261886, a special 510(k). The device falls under product code DQK, Computer, Diagnostic, Programmable, regulated at 21 CFR 870.1425 as a Class 2 device. The review panel was Cardiovascular.
FDA logged the submission as received on Jun 5, 2026. The decision came 147 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Catheter Precision, Inc. in the last 12 months of the tracker.